跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AGILUS 120 MG POLVO PARA SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
AGILUS 120 MG POLVO PARA SOLUCION INYECTABLE
Approved
STANDARD
AGILUS 120 MG POLVO PARA SOLUCION INYECTABLE
Norgine B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 11, 2024
Approval ID
cc348b94015932f7
Company
Norgine B.V.
Type
Standard
Approval Details
Approval Id
cc348b94015932f7
Drug Cima Aemps Name
AGILUS 120 MG POLVO PARA SOLUCION INYECTABLE
Register Number
1241805001
Holder Company Name
Norgine B.V.
Marketing Company Name
Norgine De Espana S.L.U.
Holder Company Detail Path
/organization/norgine-b-v
Authorization Date
2024-07-11
Dosage Form
POLVO PARA SOLUCIÓN INYECTABLE
Dose
120 MG
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Norgine B.V.
Company Detail Path
/organization/norgine-b-v
Company Information
Pharmaceutical Company Name
Norgine B.V.
Country Name
Netherlands
City Name
amsterdam,noord-holland,country_nl
Address
Antonio Vivaldistraat 150
Active Ingredients
DANTROLENO SODIO HEMIHEPTAHIDRATO
120 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 11, 2024
Approval ID
cc348b94015932f7
Type
Standard
Back to CIMA-AEMPS Approvals
